MassDevice

Study highlights effectiveness of Medtronic adaptive DBS in Parkinson’s

Medtronic (NYSE: MDT) today announced study results backing its adaptive DBS algorithm for personalized therapy in ...
Medscape

How Adaptive DBS Is Transforming Parkinson’s Treatment Across the Globe

Recently FDA-cleared, adaptive deep brain stimulation is gaining global traction, offering real-time, personalized therapy ...
Medscape

Deep Brain Stimulation for Parkinson’s Yields Lasting Benefits

Deep brain stimulation in patients with Parkinson’s disease is linked to significant motor and daily living improvements 5 ...
MobiHealthNews

Medtronic's deep brain stimulation programmer and app get the FDA nod

Medical tech company Medtronic has just landed FDA clearance on its Deep Brain Stimulation (DBS) Clinical Programmer and ActivaProgramming application. "This marks a new era of innovation from the ...
Benzinga.com

FDA Approves Medtronic's Adaptive Deep Brain Stimulation System For Parkinson's Patients

Medtronic's BrainSense aDBS personalizes Parkinson's therapy in real-time, minimizing manual adjustments for better symptom control. BrainSense Electrode Identifier speeds up initial DBS programming ...
WDAF-TV

Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's

New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever GALWAY, Ireland, Feb. 24, 2025 ...
Orange County Business Journal

Brett Wall: Leading $10B Neuroscience Unit at Medtronic

Brett Wall has overseen the neuroscience portfolio of Medtronic, one of the world’s largest medical device makers valued at ...
Seeking Alpha

Medtronic's deep brain stimulation system for Parkinson's disease wins FDA nod

Medtronic (NYSE:MDT) has won FDA approval for a deep brain stimulation system for Parkinson’s disease. The approval is for BrainSense Adaptive deep brain stimulation (DBS)and BrainSense Electrode ...
Fierce Healthcare

New Data in the New England Journal of Medicine Show Medtronic Deep Brain Stimulation Provides Sustained Motor Function Im

MINNEAPOLIS--(BUSINESS WIRE)-- In the largest, randomized, controlled study of deep brain stimulation (DBS) for Parkinson’s disease, Medtronic DBS Therapy was shown to improve motor function for up to ...
Healio

Q&A: Removing barriers to access key to expansion of DBS surgery for Parkinson’s

Please provide your email address to receive an email when new articles are posted on . Offering asleep or awake DBS aims to provide PD patients choice, impetus for choosing DBS therapy sooner.
AOL

FDA Approves Medtronic's Adaptive Deep Brain Stimulation System For Parkinson's Patients

On Monday, the FDA approved Medtronic plc’s (NYSE:MDT) BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier (EI) for patients with Parkinson’s disease. Deep brain ...
Seeking Alpha

Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's

New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever There is no cure for debilitating ...